Cathy Friedman - Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cathy Friedman since 11/12/2023

Holdings reported by Cathy Friedman for Lyell Immunopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 236K $539K $2.28 Jun 14, 2024 MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST
Common Stock 100K $228K $2.28 Jun 14, 2024 The Duane Irrevocable Trust 2020
Option (right to buy) 130K Jun 14, 2024 Direct Common Stock

Transactions reported by Cathy Friedman for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.